Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection

Biochemical and Biophysical Research Communications

Volumn 447, Issue 3, 2014, Pages 550-555

  Zhang, Wei ^a,b   Zhang, Lei ^a   Wu, Zhiyong ^a   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Coxsackievirus A16; Enterovirus 71; Interferon stimulated genes; JAK STAT pathway; PCR array

Indexed keywords

INTERFERON; JANUS KINASE; STAT PROTEIN;

ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS INFECTION; CYTOTOXICITY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GENE EXPRESSION; HAND FOOT AND MOUTH DISEASE; HUMAN; HUMAN CELL; IMMUNOGENETICS; PRIORITY JOURNAL; RHABDOMYOSARCOMA CELL LINE;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS 71;

COXSACKIEVIRUS A16; ENTEROVIRUS 71; INTERFERON-STIMULATED GENES; JAK-STAT PATHWAY; PCR ARRAY;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; DRUG RESISTANCE, VIRAL; ENTEROVIRUS A, HUMAN; HAND, FOOT AND MOUTH DISEASE; HUMANS; INTERFERON TYPE I; JANUS KINASES; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84900300296     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.021     Document Type: Article

References (25)

1. Li X.J., Fan P.H., Jin J., Su W.H., An D., Xu L., Sun S.Y., Zhang Y., Meng X.Y., Gao F., Kong W., Jiang C.L. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol. J. 2013, 10:250-261.
2. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of Enterovirus 71 infection in Taiwan. N. Engl. J. Med. 1999, 341:929-935.
3. Nishimura Y., Wakita T., Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 2010, 6:e1001174.
4. Jin J., Han M.M., Xu L., An D., Kong W., Jiang C.L. Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells. Virol. Sin. 2012, 27:221-227.
5. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002, 26:91-107.
6. Lum L.C., Chua K.B., McMinn P.C., Goh A.Y., Muridan R., Sarji S.A., Hooi P.S., Chua B.H., Lam S.K. Echovirus 7 associated encephalomyelitis. J. Clin. Virol. 2002, 23:153-160.
7. Ong C.K., Devi S., Cardosa J.M., Wong T.K. Formaldehyde-inactivated whole-virus vaccine protects a murine model of Enterovirus 71 encephalomyelitis against disease. J. Virol. 2010, 84:661-665.
8. Platanias L.C. Mechanisms of type I and type II interferon mediated signaling. Nat. Rev. Immunol. 2005, 5:375-386.
9. García-Sastre A., Biron C.A. Type I interferons and the virus-host relationship: a lesson in détente. Science 2006, 312:879-882.
10. Sen C.G. Virus and interferons. Ann. Rev. Microbiol. 2001, 55:255-281.
11. Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., Lugwid S. Influenza A virus inhibits type I IFN signaling via NF-kB dependent induction of SOCS-3 expression. PLoS Pathog. 2008, 4:e1000196.
12. Zhang T., Lin R.T., Li Y., Douglas S.D., Maxcey C., Ho C., Lai J.P., Wang Y.J., Wan Q., Ho W.Z. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. Hepatology 2005, 42:819-827.
13. Jones M., Davidson A., Hibbert L., Gruenwald P., Schlaak J., Ball S., Foster R.G., Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 2005, 79:5414-5420.
14. Mindy S.L., Brazas M.R., Holtzman J.M. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of stat2 expression and alpha/beta interferon responsiveness. J. Virol. 2005, 79:9315-9319.
15. Lei X.B., Sun Z.M., Liu X.L., Jin Q., He B., Wang J.W. Cleavage of the adaptor protein TRIF by Enterovirus 71 3C inhibits antiviral responses mediated by Toll-Like Receptor 3. J. Virol. 2011, 85:8811-8818.
16. Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012, 86:3767-3776.
17. Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of Enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010, 84:8051-8061.
18. Yohichi K., Day C.W., Wandersee M.K., Schow B.P., Madsen J.S., Grant D., Blatt L.M., Barnard D.L. Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. Biochem. Biophys. Res. Commun. 2008, 371:110-113.
19. Kuo R.L., Kung S.H., Hsu Y.Y., Liu W.T. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 2002, 83:1367-1376.
20. Kuo R.L., Kao L.T., Lin S.J., Wang Y.L., Shih S.R. MDA5 plays a crucial role in Enterovirus 71 RNA mediated IRF3 activation. PLoS One 2013, 8:e63431.
21. Blackwell J.M., Jamieson S.E., Burgner D. HLA and infectious diseases. Clin. Microbiol. Rev. 2009, 22:370-385.
22. Raychoudhuri A., Shrivastava S., Steele R., Kim H., Ray R. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 2011, 85:12881-12889.
23. Askarieh G., Alsiö A., Pugnale P., Negro F., Ferrari C., Neumann A.U., Pawlotsky J.M., Schalm S.W., Zeuzem S., Norkrans G., Westin J., Söderholm J., Hellstrand K., Lagging M. DITTO-HCV and NORDynamIC Study Groups. Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology 2010, 51:1523-1530.
24. Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 2008, 283:13116-13123.
25. Reissner K.J., Kalivas P.W. Using glutamate homeostasis as a target for treating addictive disorders. Behav. Pharmacol. 2010, 21:514-522.